Gujarat Exclusive >

Adar Poonawalla

Man files complaint against Adar Poonawalla, claims “no antibodies developed after taking Covishield

A Lucknow resident, Pratap Chandra, has filed a complaint against Pune-based Serum Institute of India’s (SII) CEO Adar Poonawalla, health ministry’s joint secretary Luv Agarwal, Indian Council of Medical Research director Balram Bhargava, and National Health Mission director Aparna Upadhyay, claiming that he did not develop any antibody against COVID-19 after taking a...

Serum Institute reduces ‘Covishield’ price for state governments

Pune-based Serum Institute of India that manufactures ‘Covishield’—a jab against COVID-19 developed jointly by AstraZeneca and the University of Oxford—has announced that it will charge Rs 300 from the state government for each shot. Notably, the announcement comes a few days after Serum Institute chief Adar Poonawalla revealed that the shot will cost Rs 400...

Adar Poonawalla urges Joe Biden to lift embargo on export of raw materials for COVID-19 vaccines

Pune-based Serum Institute of India’s CEO Adar Poonawalla has urged US President Joe Biden to lift the embargo on raw material exports that are required for the manufacturing of vaccines. Notably, the Serum Institute is manufacturing the jab ‘Covishield’ jointly developed by AstraZeneca and the University of Oxford. Notably, Covishield is one of the most...

Update: Fire in Serum Institute premises in Pune kills 5

In an unfortunate development, five people lost their lives in the fire that broke out at Pune’s Serum Institute of India. Notably, the deceased were reportedly working in the under-construction building in SII premises where the fire broke at around 2.45 pm. The news was broke by SII chief Adar Poonawalla. He said, “We have...

SII to sell COVID-19 vaccine for Rs 2,000 for two doses after government nod

Serum Institute of India (SII) chief Adar Poonawalla has said that the ‘Covishield’ vaccine that has been approved by the Indian drug regulator for restricted emergency use will be available at Rs 1,000 per shot in the retail market, if the government gives a nod for its private sale. Poonawalla said SII is selling the...

SII chief wants govt to indemnify vaccine manufacturers from lawsuits during pandemic

Serum Institute of India (SII) chief Adar Poonawalla has requested the Union government to indemnify it against litigations related to their vaccines, especially during a pandemic. He said vaccine manufacturers need to have protections against lawsuits and that they are going to propose the same to the government. Poonawalla said this while speaking at a...

Controversy erupts over AstraZeneca’s COVID-19 vaccine efficacy claim

At a time when the low-cost COVID-19 vaccine candidate jointly developed by AstraZeneca and Oxford University seems to raise hopes for many countries including India, experts have raised questions on the manner in which the company arrived at the efficacy percentage for its vaccine candidate. The questions were raised after AstraZeneca and Oxford University acknowledged...

10 crore AstraZeneca-Oxford vaccine will be available by January: Adar Poonawalla

After AstraZeneca and the University of Oxford declared that their COVID-19 vaccine candidate has efficacy of upto 90 per cent with an average efficacy pegged at 70 per cent, Serum Institute of India (SII) chief Adar Poonawalla said that a minimum of 100 million doses of its vaccine ‘Covishield’ will be available by January for...